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Trace elements in serum, packed cells and dialysate of CAPD patients.
Neutron Activation Analysis (NAA) was used to investigate trace
element patterns in serum, packed cells, and dialysate of CAPD
patients. The concentrations of the elements Cs, Cu, Fe, and Mn in
serum and packed cells appeared to be maintained within the normal
range, while the levels of the non-essential element Br in both serum
and packed cells were subnormal. The serum Cr values were extremely
high (20 to 50 times higher than the normal serum level). The amount of
Cr absorbed from the dialysate was calculated to be ten times higher
than the daily dietary uptake. The Co concentrations were normal in
packed cells but were significantly increased in serum. The Rb content
in packed cells was slightly lower than normal, while the serum value
was normal. Se was maintained within the normal range in packed cells,
but the serum concentration was slightly lower than normal. The
concentrations of Zn were low in serum and appeared to be higher than
normal in packed cells. In conclusion, this analysis of the trace element
status of CAPD patients reveals two major abnormalities. There is an
apparent loss of Br from the blood towards the dialysate and on the
other hand, a dramatic accumulation of Cr into the blood as a result of
the very high Cr content in the dialysate.
Over the last few years, several research groups investigated
the effect of renal failure on the status of trace elements in the
uremic patient [1—61. Most attention has been focused on the
blood and tissue accumulation of aluminum in uremic patients
who were not yet in dialysis, or with end-stage renal failure
either on hemodialysis or on continuous ambulatory peritoneal
dialysis (CAPD) [7, 81.
As far as we know, only two studies have been devoted to a
description of the status of trace elements other than aluminum
in patients on CAPD [3, 61.
Thomson et al [3] described recently a cross-sectional anal-
ysis of plasma and red cell concentrations of zinc (Zn), copper
(Cu), aluminum (Al), manganese (Mn), lead (Pb), cadmium (Cd)
and chromium (Cr). They found significant alterations, such as
a decrease in Zn plasma and red cells, a reduction in red cell Cu,
an increase in plasma Al, and increased concentrations of whole
blood Cr in their CAPD patients.
On the other hand, Armstrong et al [6], described serial
measurements at start and after six months of aluminum (Al),
fluoride (F), zinc (Zn) and copper (Cu) in plasma of CAPD
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patients. Whereas zinc and copper levels were found to be
normal, persistent elevated concentrations of aluminum and
fluoride were noted.
Both studies used graphite furnace atomic absorption spec-
trometry, and the trace elements in dialysate were not investi-
gated.
The present study reports on the trace element profiles in
serum, packed cells, and fresh and spent dialysate of patients
on CAPD. Transperitoneal transport of trace elements may
occur bidirectionnally, which might result in either accumula-
tion or depletion of some elements. Neutron activation analysis
(NAA) was used to analyze the samples, a technique with both
high sensitivity and specificity and which often serves as a
reference for other methods.
Methods
The trace elements Br, Co, Cr, Cs, Cu, Fe, Mn, Rb, Se, and
Zn were determined in serum, packed blood cells, and dialysate
of five CAPD patients during a single dwell of six hours. Packed
blood cells include red blood cells, leucocytes and platelets.
The alterations observed in one patient before starting CAPD
and after two months of treatment are described as well. The
most relevant clinical data of the five patients at the time of
investigation are summarized in Table 1.
A first blood sample was taken before fresh dialysate was
introduced and the second, six hours later when the dialysate
was drained. Samples of both fresh and spent dialysate were
also analyzed.
For the determination of the trace elements, the neutron
irradiations were performed in a nuclear reactor. Radiochemi-
cal separations were required for the elements Cr, Cu and Mn.
The quantitative determination is based on y-spectrometry with
a Ge(Li) detector. The isotopes measured are t2Br, 60Co, Cr,
'34Cs, MCu, 59Fe, 56Mn, t6Rb, 75Se, and 65Zn.
The blood samples were collected with the aid of a plastic
cannula trocar (Intranule 110 16, Vygon), flushed with 20 ml
blood before the actual sampling in ultra-clean Suprasil Heraeus
quartz vials. The fresh dialysate was sampled directly from the
bag before the treatment. Six hours later, a sample was taken
from the liquid draining out of the peritoneal cavity. All further
sample handling was performed in a dust-poor room.
The blood was allowed to clot spontaneously for one hour
and the serum was then separated from the packed cells by
centrifugation. Serum and packed cell samples were lyophilized
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Table 1. Data concerning the five patients on CAPD
Patient Age Start of Sampling
Number yr Sex dialysis date Diagnosis
I 65 M 03101179 14/07/80 Chronic pyelonephritis
2 60 M 20/02/80 23/01/81 Analgesic ncphropathy
3 67 F 13/09/79 09/03/81 Analgesic nephropathy
4 64 M 05/01/82 12/03/82 Urate nephropathy
5 37 F 12/10/82 11/10/82
15/12/82
Alport syndrome
and the dialysate samples were dried at 40°C. For all serum and
dialysate samples, the individual volume to dry weight ratio,
and for packed cells the individual wet mass to dry weight ratio
has been determined.
For the determination of Cu and Mn, either 100 mg lyophi-
lized serum or 250 mg packed cells or 30 mg dried dialysate
were irradiated for three hours at a thermal neutron flux of 2.5
1012 n.cm2.s1 (Thetis reactor, Gent, Belgium). After irradia-
tion, the samples were digested in a mixture of 1: 1 14 N
HNO1:70% HC1O4, followed by extraction of Cu at pH = 2 and
of Mn at pH 8 with 8-hydroxyquinoline in CHC13.
Determination of Br was performed on samples of 100 mg of
lyophilized serum, of 250mg lyophilized packed blood cells (the
equivalent of I ml) and of 30 mg of dried dialysate (the
equivalent of I ml) in a purely instrumental way, after a three
hour irradiation at 1012 n.cm 25I
For the simultaneous determination of Co, Cs, Fe, Rb, Se
and Zn, samples containing approximately 25 mg of serum, 80
mg of packed cells or 5mg of dried dialysate, were irradiated for
12 days at a neutron flux of 1013 n.cm2.s' (BR II reactor, Mol,
Belgium), The activated samples were wet ashed in a mixture of
1:1 FIC1O4 and HNO3, and the induced activities of the isotopes
60Co, °4Cs, 59Fe, 56Rh, 73Se and 65Zn were registered.
The analysis of Cr required 12 days of irradiation at l0'
n.cm2.s' (BR II reactor). As the pressure in the irradiation
vials, caused by radiation damage of the organic material,
would become too high, the activation was performed on circa
100 mg of dry-ashed serum or on 30 mg of dry-ashed dialysate.
After irradiation, the samples were dissolved in HCIO4:HNO1.
The 51Cr activity was separated from the matrix radioactivity by
distillation of Cr as CrO,C12 at 200°C in the presence of 5 mg
carrier. The determination of Cr in packed cells was not
possible due to interference caused by the high Fe content of
packed blood cells (1025 j.rg.g1). There would occur a thresh-
old reaction 54Fe (l, a) 51Cr caused by fast fission neutrons
(4sat). Taking into consideration a Mermaii4rast = 6 neutron flux
ratio, the apparent concentration of Cr caused by the nuclear
interference would be circa 11 ng chromium.g' packed cells.
On the other hand, it has been estimated that the amount
endogenously present is 0.55 ng.g packed cells [9].
The results are given as means standard deviations.
Statistical significance of differences between the results was
determined by Student's t-test. Significance was accepted with
P 'C 0.05.
Results
The mean concentrations of duplicate analyses of trace
elements in the sera of the five CAPD patients before and after
a single CAPD exchange are given in Table 2. As will he
explained later, the mean value for Br was calculated without
taking into account the value for patient number 5. As expected
from a continuous dialysis, no significant differences between
the serum values at start and at the end of one single dialysis
dwell could be detected for the 10 investigated trace elements.
The normal levels in healthy individuals for Br [10], Co [11, 121,
Cr [12], Cs, Fe, Rh, Se, Zn [13] and Cu and Mn [14] are also
included in this table. The normal values have been published
by us and others previously. Although the mean age of the
CAPD patients was slightly higher than our controls, the latter
group included individuals between 20 and 70 years of age, and
as far as we know no dependency of trace element concentra-
tions and age has ever reliably been demonstrated.
Data for the packed cells are summarized in Table 3. The
mean Br level was again calculated for only four patients. No
significant differences were observed between the values at
start and end of the dialysis dwell.
The concentrations in the fresh as well as in the spent
dialysate are given in Table 4. Statistical analysis reveals
significant differences in the contents of trace elements in the
drained dialysate for all elements, except Fe and Co.
Blood of patient number 5 (Table I) was collected one day
before the start of CAPD treatment, and again after two months
of CAPD. Table S allows the comparison of the trace element
concentrations in serum and packed cells before and during this
treatment interval in this patient. The nearly 15-fold increase of
serum Cr is remarkable. The relatively high Br content should
be noted.
Discussion
Because of the often extremely low concentrations of several
of these trace elements, extreme care during the sample collec-
tion and handling stages as well as considerable analytical
sensitivity is required. Neutron activation analysis is one of the
most sensitive trace techniques and is characterized by an
effective elimination of problems of contamination and loss of
elements. Although time consuming and expensive, it guaran-
tees a high accuracy and a sensitivity as low as 0.01 to 0.005 ng
Cr in the irradiation facilities described above. Until now, few
investigators were able to measure the correct value of Cr in
serum of healthy individuals, that is, 0.16 ng Cr.mY1 [15].
The concentrations of the element Br, in both serum and
packed blood cells of patients I to 4, fall far below the normal
range (Tables 2, 3). The increase of the Br in the dialysate
(Table 4) indicates that some Br leaves the body across the
peritoneum. it is therefore conceivable that the Br stores of
these patients ultimately become depleted by this form of
continuous dialysis treatment. Subnormal blood Br levels were
already reported for patients on hemodialysis [16, 17], and have
been hypothetically related as a cause for the insomnia in
dialyzed patients [17]. The Br levels in the serum and the
packed blood cells of the patient in terminal renal failure, just
before the start of CAPD (Table 5) was slightly lower than the
normal mean. After two months of CAPD, however, the Br
concentration had risen respectively to 6.09 rg.ml' in serum
and to 4.69 rg.g1 in packed cells. These elevated Br levels are
probably due to the use of halothane anesthesia, applied at the
time of implantation of the Tenckhoff catheter. Elevated serum
bromine levels following halothane anesthesia have been de-
scribed [18]. The serum half life of the introduced Br has been
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Table 2. The mean SD of trace element concentrations in the serum of five CAPD patients, at the start and at th
session, as compared to the normal values
e end of a single dialysis
CAPD patients
Normal individuals1 Start 2 End Overall
Element mean SD mean SD Ratio mean SD mean SD
Br (g . m1') 1.03 0.12 1.01 0.16 0.98 1.02 0.13a 4.87 2.02(N = 4) (N = 4) (N = 8) (N = 10)
Co (ng . m1') 0.33 0.11(N = 5)
0.30 0.10 0.91
(N = 5)
0.31 0.l0a
(N 10)
0.11 0.06
(N = 17)
Cr (ng ml') 4.30 1.92(N = 5)
4.20 1.71 0.98
(N = 5)
4.25 1.71'
(N 10)
0.16 0.08
(N = 10)
Cs (ng . ml) 0.98 0.18(N = 5) 1.03 0.39 1.05(N = 5) 1.01 0.28(N = 10) 0.74 0.25(N 36)
Cu (,ttg . ml) 1.20 0.36(N = 5) 1.15 0.37 0.96(N = 5) 1.17 0.35(N = 10) 1.07 0.24(N = 46)
Fe (gig . m11) 1.25 0.39(N = 5)
1.17 0.40 0.94
(N = 5)
1.21 0.37
(N = 10)
1.63 0.43
(N = 36)
Mn (ng . m1') 0.58 0.11(N = 5)
0.59 0.09 1.02
(N = 5)
0.58 0.09
(N = 10)
0.57 0.13
(N = 46)
Rb (g . m11) 0.17 0.02(N = 5)
0.16 0.03 0.94
(N 5)
0.17 0.02
(N 10)
0.17 0.04
(N = 36)Se (g . m1') 0.10 0.02(N = 5)
0.09 0.02 0.90
(N = 5)
0.10 0.02a
(N = 10)
0.13 0.02(N 36)
Zn (tg . ml) 0.85 0.15(N = 5) 0.74 0.09 0.87(N = 5) 0.80 0.l3(N = 10) 1.13 0.20(N = 36)
a Significant versus normal value; P < 0.05.
N = number of different samples.
Table 3. The mean SD of trace element conce
di
ntrations in the packed blood cells of five CAPD patients, at the start and a
alysis session, as compared to the normal values
t the end of a single
CAPD patients Normal
individuals1 Start 2 End Overall
Element mean SD mean SD Ratio mean SD mean SD
Br (zg . g) 0.48 0.11(N = 4) 0.47 0.08 0.98(N = 4) 0.47 0.09a(N = 8) 4.14 1.44(N = 10)
Co (ng . g') 0.52 0.27(N = 5) 0.49 0.17 0.94(N = 5) 0.50 0.22(N = 10) 0.59 0.23(N = 6)
Cs (ng . g) 5.72 1.80(N = 5) 5.56 1.70 0.97(N = 5) 5.64 1.65(N = 10) 4.82 2.10(N = 36)
Cu (g . g') 0.66 0.17
(N = 5)
0.62 0.14 0.94
(N = 5)
0.64 0.15
(N = 10)
0.66 0.08
(N = 46)
Fe (g . g1) 1101 85 1050 113 0.95 1076 98 1025 136
(N = 5) (N = 5) (N = 10) (N = 36)
Mn(ng . g) 11.6 5.4
(N = 5)
10.7 4.1 0.92
(N = 5)
11.1 4.5
(N = 10)
15.0 4.9
(N = 46)
Rb (g . g) 3.53 0.09
(N = 5)
3.45 0.24 0.98(N = 5)
3.49 0.l8a
(N = 10)
4.28 0.98
(N = 36)Se (g . g') 0.14 0.02
(N = 5)
0.15 0.01 1.07
(N 5)
0.14 0.02
(N = 10)
0.16 0.03
(N = 36)
Zn (.tg . g) 14.3 1.0
(N = 5)
13.7 1.0 0.96
(N = 5)
14.0 l.Oa
(N = 10)
11.1 1.8
(N = 36)
a Significant versus normal value; P < 0.05.
N = number of different samples.
calculated to be 12 days for patients with normal renal function.
From the data obtained at the start and end of one single
peritoneal dialysis exchange, it appears that Br leaves the blood
across the peritoneum with a half-life of about 24 hours, which
is in good agreement with the value found by Cornelis et al [16]
for patients on hemodialysis.
Co concentrations in the serum of the CAPD patients appear
to be significantly higher than in normals, whereas Co in the
packed cells is normal. The situation for the uremic patient
number 5 prior to CAPD therapy is similar as for patients on
peritoneal dialysis. Co appears to be low in dialysate and
remains unchanged. These findings for serum are in accordance
with the results of Lins and Pehrsson [191, who conclude that
uremic patients have elevated serum Co values, and that
hemodialysis treatment does not reduce, but rather increases
the serum Co concentrations. Although cobalt is relatively
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Table 4. The mean so of trace element concentrations in the fresh
and spent dialysate of the CAPD patients
Element
1 Start
mean so
2 End
mean SD Ratio
Br (jig . mr') 0.51 0.17(N=5) 0.98 0.20(N=4) 1.92
Co (ng ml) 0.08 0.07(N5) 0.09 t (1.06(N=5) 1.13
Cr (ng mE') 1.22 0.47 0.74 0.16 0.6!(N=5) (N5)
Cs (ng . mE') <0.07(N5) 0.67 t 0.48(N=5) > 9.57
Cu (jig mE') 0.009 0.004(N=5) 0+022 0.003(N=5) 2.44
Fe (jig mE') <0.157(N=5)
<0.21(N5) —
Mn (ng mE') 0.41 0.10(N5) 0.16 0.08(N5) 0.39
Rb (jig . mE') <0.069 0.12 0.06 > 1.74(N=5) (N5)
Sc (jig + mE') <0.002(N5) 0.003 0.002(N=5) > 1.50
Zn (jig . mE') 0.055 0.013 0.021 0+007 0.38(N=5) (N=5)
N = number of different samples.
non-toxic, it is an open question whether these prolonged
increased Co serum values may induce side effects in the CAPD
patient population.
The mean serum Cr values of our CAPD patients are about 26
times higher than the normal mean. The concentration of Cr in
the fresh diatysate is exceptionally high, up to eight times the
normal serum value. In this study, it is the only trace element in
the dialysate to exceed the normal serum level. The study of the
serum Cr content of patients on chronic hemodialysis revealed
similar high Cr levels, with a mean SD value of 2.22 1.33 ng
ml' (N 6) [201. The amount of Cr absorbed in the body
during a single peritoneal dialysis exchange was estimated from
the decrease of Cr in the dialysate (Table 4). Taking into
consideration an increase in dialysate volume of 300 ml at the
end of one CAPD exchange, due to ultrafiltration, the uptake of
Cr from the dialysate was caluclated to be around 0.74 jig Cr
per exchange, or 3.0 jig Cr per day. This amount is about ten
times higher than that estimated to he absorbed daily from a
normal diet, which is 0.5% from a normal dietary intake of 60
jig/day [21, 22]. The urinary tract functions as an important
excretory pathway of Cr [23]. The mean residual renal function
of our CAPD patients being only 1.5 mI/mm, an accumulation of
Cr in different target organs is therefore conceivable. This
chromium load, which will be mainly under its trivalent form
(Cr (III)), may be associated with toxic effects. It has been
suggested [24] that chromium, irrespective of its oxidation
state, may affect the vascular system by inducing thickening of
renal blood vessels, perivascular inflammation in brain, and
degeneration of myofibrils in the cndocardial region. Further-
more, trivalent chromium is known to interact with DNA
synthesis and to cause infidelity in DNA replication [24].
Therefore, a more profound investigation of the peritoneal Cr
kinetics is warranted. In addition, the Cr concentration in the
serum of patient number S appeared to be normal (0.28 ng.mE')
prior to the CAPD treatment. Two months later, however, this
value had risen to 4.0 ng.m1' serum.
Halls et al [25] recently confirmed our findings about the
accumulation of Cr in the serum of patients on either
hemodialysis or on CAPD [20, 26]. They reported serum Cr
levels of 7.5 1.7 ng.ml for CAPD patients, 6.2 2.1
ng.mE' for patients on hemodialysis and 0.2 0.2 ng.mE' for
their controls. They also suggested that these high levels are not
a consequence of the uremic state, but are rather the result of
Cr transfer from the dialysate into the body.
Thomson et al [3] described increased total blood Cr levels in
patients on dialysis. Although the increase observed, from 3.64
1.04 og.mr' for controls up to 8.31 10.91 ng.mE' and 8,32
2.86 ng.mE' for patients on hemodialysis and on CAPD,
respectively, is less pronounced than in our hands, and those of
Halls et al [25], this can presumably be explained by their much
higher normal values.
The values published by Minami et a! [27] tbr patients on
hemodialysis should be interpreted with caution. Their Cr
values of circa 21 and 32 jigg serum for respectively male and
female controls are suspiciously high, and should be considered
inaccurate in the light of present knowledge 115]. These authors
described a decrease to circa 13 and 5jigg serum for male
and female patients on hemodialysis, but this observation and
their clinical conclusion seems questionable.
Although the clinical relevance of these very elevated chro-
mium levels in CAPD is not yet clear, efforts should be
undertaken by the industry to avoid presence of more than 1 ng
Cr,ml 'in the final dialysate.
The Cs concentrations in both serum and packed cells are in
the normal range. The concentrations of Cs in the fresh dialy-
sate appear to be extremely low, but they increase approxi-
mately ten times at the end of one single dwell. The concentra-
tions in serum and packed cells of the uremic patient prior to
CAPD are higher than normal. Two months later, however, the
serum levels become normal, while the levels in packed cells
remain higher than normal. We have previously investigated the
influence of hemodialysis on the Cs concentration of serum and
packed cells [28]. The concentration in serum appeared to be
higher than normal at the start, and lower than normal at the
end of one hemodialysis session. In contrast, the levels in
packed cells were normal and remained unchanged.
Cu levels appear to he normal in both serum and packed cells.
The Cu concentration of the fresh dialysate is about 100 times
lower than the normal serum Cu value, and it doubles after one
exchange. The Cu levels in serum and packed cells of patient
number 5 prior to CAPD are normal as well (Table 5), Thomson
et al [31 also observed constant serum Cu values, but on the
contrary, they described a spectacular decrease in red blood
cell Cu compared with their normal population. It should,
however, be noted that their normal Cu red cell values are much
higher than what is generally accepted.
The Fe concentrations in both serum and packed cells of the
CAPD patients are normal. The level in the dialysate remains
below the detection limit. The Fe concentration in the serum of
patient number 5 prior to the start of the CAPD treatment is
lower than normal, and has risen somewhat after two months of
treatment. The Fe levels in serum and packed cells in patients
on hemodialysis have also been found to he normal [26].
Mn is normal in both serum and packed blood cells of the
patients. The Mn content of the fresh dialysate is comparable
with the normal serum value, hut it decreases to half its original
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Table 5. The trace element concentrations in serum and packed cells of uremic patient number 5 one day before the onset of the CAPD
treatment, compared with the data after two months CAPD treatmenta
Conservative treatment CAPD treatment
Element
serum ml packed cells g dialysate mlpacked cells
serum ml g cone. Start conc. End conc. Start conc. End cone. Start cone. End cone.
cone. SD SD SD SD SD SD SD SD
Br (pg)
Co (ng)
Cr (ng)
Cs (ng)
Cu (big)
Fe (.tg)
Mn (ng)
Rb (pg)
Se (pg)
Zn (pg)
2.88 0.03 3.47 0.03 6.09 0.04 5.27 0.07 4.69 0.09 4.37 0.08 0.46 0.05 5.46 0.16
0.35 0.05 0.43 0.04 0.21 0.04 0.21 0.01 0.30 0.06 0.37 0.09 0.02 0.01 0.03 0.0!
0.28 0.01 — 4.11 0.03 4.01 0.02 — — 1.27 0.01 0.75 0.01
2.42 0.10 12.04 0.76 1.06 0.07 1.67 0.07 8.06 0.26 8.04 0.16 0.07 0.02 1.08 0.02
1.08 0.01 0.60 0.01 1.04 0.01 0.94 0.01 0.61 0.01 0.65 0.01 0.005 0.001 0.024 0.001
0.86 0.04 1175 5 0.75 0.03 0.87 0.03 953 4 859 3 0.08 0.01 0.17 0.01
0.69 0.04 16.5 0.4 0.72 0.04 0.62 0.04 18.9 0.3 15.8 0.3 <0.01 <0.01
0.21 0.01 4.39 0.05 0.13 0.01 0.17 0.01 3.60 0.06 3.29 0.05 4.2 lO 1.7 io 0.14 0.01
0.08 0.01 0.16 0.01 0.08 0.01 0.08 0.01 0.12 0.01 0.14 0.01 <2 iO 2.3 iO 0.2 IO
0.81 0.01 18.1 0.04 0.83 0.01 0.67 0.01 12.8 0.2 12.6 0.1 0.056 0.001 0.012 0.001
a Standard deviation on the duplicate analyses, due to counting statistics.
value after the dwell. The concentration in the serum and the
packed cells of patient number 5 before the onset of the dialysis
is normal and appears unaltered after two months of the
treatment. A similar observation was made by Thomson et al [31
for patients on hemodialysis; however their normal values, that
is, 3.8 1.8 ng.ml plasma, appear to be aberrantly high and
can eventually be attributed to contamination of the samples
during sampling, sample handling, and analysis [101.
Rb in serum is normal, but in packed cells it is distinctively
below normal. Rb is hardly detectable in the fresh dialysate, but
it increases at least with a factor of two after draining. The Rb
level in the packed cells of the uremic patient before CAPD
appears to be normal (Table 5). Two months later, this value
decreased and reached the level found in the other patients.
Aifrey and Smythe [51 and Cornelis et al [28] described a
decrease in Rb levels in patients on hemodialysis, most likely as
a result of its removal across the dialyzing membrane.
Serum Se levels appear to be slightly lower than normal,
while the concentration in packed cells is normal. The level in
dialysate is very low. A low Se serum level was found in the
undialyzed uremic patient and the situation remained unaltered
after two months of CAPD (Table 5). Similar values were
obtained by Cornelis et al [281 for patients on hemodialysis.
Zn levels in the serum of CAPD patients are significantly
below normal, but the values in packed cells appear to be higher
than in normal controls. The Zn concentration in the dialysate
is very low, and is reduced by more than half after one dwell.
Low serum and increased packed cells Zn levels were also
observed in the uremic patient, prior to CAPD (Table 5) and
similar abnormalities have been noted in serum and packed
cells of non-dialyzed and dialyzed uremic patients [1, 28]. Zinc
deficiency in uremic patients has been associated with distur-
bances in taste and sexual performance.
In conclusion, the anaylsis of the trace elements Br, Co, Cr,
Cs, Cu, Fe, Mn, Rb, Se, and Zn in the sera, packed cells, and
dialysate of five CAPD patients before and after a single dialysis
session, reveals two major abnormalities. Br levels apper to be
decreased in serum and packed cells while the dialysate con-
centrations double after one exchange. The dramatic increase
of the Cr serum concentration is the most intriguing finding.
Further studies to characterize the transperitoneal Cr transport
and the different Cr species in dialysate and blood will be
needed.
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